中商官网
研究报告
药明康德（HK2359）
| 科目\年度 | 2025-06-30 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
838375.00 | 946895.40 | 1079787.00 | 890261.10 | 513594.70 | 298625.00 | 191140.90 | 233368.10 | 129672.00 | 112097.30 | 68377.90 |
| 营业收入 |
2040510.00 | 3791778.00 | 4034081.00 | 3935478.00 | 2290239.00 | 1653543.00 | 1287221.00 | 961368.40 | 776525.90 | 611613.10 | 488334.90 |
| 销售成本 |
1134233.00 | 2164651.00 | 2396834.00 | 2484826.00 | 1463687.00 | 1028039.00 | 786605.80 | 583676.50 | 452534.00 | 363364.00 | 320471.80 |
| 税前利润 |
972739.30 | 1328054.00 | 1338895.00 | 1061848.00 | 601560.90 | 336937.60 | 233696.80 | 258082.40 | 159262.00 | 138217.50 | 80134.90 |
| 归属于母公司股东利润 |
828731.90 | 935260.80 | 1069000.00 | 881084.50 | 509255.70 | 295361.30 | 185128.80 | 226052.30 | 122709.30 | 97497.99 | 34896.80 |
| 营业收入 |
2040510.00 | 3791778.00 | 4034081.00 | 3935478.00 | 2290239.00 | 1653543.00 | 1287221.00 | 961368.40 | 776525.90 | 611613.10 | 488334.90 |
| 其中：营业额 |
2040510.00 | 3791778.00 | 4034081.00 | 3935478.00 | 2290239.00 | 1653543.00 | 1287221.00 | 961368.40 | 776525.90 | 611613.10 | 488334.90 |
| 销售成本 |
1134233.00 | 2164651.00 | 2396834.00 | 2484826.00 | 1463687.00 | 1028039.00 | 786605.80 | 583676.50 | 452534.00 | 363364.00 | 320471.80 |
| 毛利 |
906277.40 | 1627127.00 | 1637247.00 | 1450652.00 | 826551.50 | 625504.40 | 500614.80 | 377691.90 | 323992.00 | 248249.10 | 167863.10 |
| 加：其他收入 |
298599.30 | 195406.10 | 231890.70 | 185600.10 | 192215.90 | 60951.60 | 6065.00 | 75700.50 | 17377.90 | 23687.30 | 38744.10 |
| 减：销售费用 |
37469.50 | 63817.10 | 70103.00 | 73158.70 | 69897.00 | 58845.90 | 43854.00 | 33787.80 | 29151.00 | 20043.90 | 18580.70 |
| 管理费用 |
166009.10 | 376424.50 | 443557.60 | 455778.60 | 319585.60 | 256296.70 | 209938.90 | 158912.50 | 129218.80 | 104922.70 | 99489.10 |
| 财务费用 |
16407.50 | 23613.60 | 19358.10 | 15983.70 | 12833.30 | 19603.30 | 12801.90 | 9240.70 | 4854.70 | 1636.00 | 2812.50 |
| 经营溢利特殊科目 |
-36278.10 | -55130.60 | -35430.20 | -24856.40 | -3161.50 | -5697.30 | -4316.50 | -1052.10 | -14019.40 | -2868.00 | -2650.70 |
| 经营溢利 |
948712.50 | 1303547.00 | 1345651.00 | 1066475.00 | 613289.90 | 346012.80 | 235768.50 | 250399.30 | 164126.00 | 142465.80 | 83074.20 |
| 加：应占联营公司业绩 |
24020.10 | 25213.80 | -3507.60 | -5253.20 | -9216.20 | -7683.30 | 1858.90 | 10460.10 | -2158.90 | -1343.90 | -1179.10 |
| 应占共同控制实体业绩 |
6.70 | -707.30 | -3248.40 | 626.10 | -2512.90 | -1391.90 | -3930.60 | -2777.00 | -2705.10 | -2904.40 | -1760.20 |
| 税前利润 |
972739.30 | 1328054.00 | 1338895.00 | 1061848.00 | 601560.90 | 336937.60 | 233696.80 | 258082.40 | 159262.00 | 138217.50 | 80134.90 |
| 减：所得税费用 |
121210.30 | 198249.10 | 213173.10 | 171586.60 | 87966.20 | 38312.60 | 42555.90 | 24714.30 | 29590.00 | 26120.20 | 11757.00 |
| 加：税后利润特殊科目 |
-13154.00 | -182909.00 | -54449.90 | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
838375.00 | 946895.40 | 1079787.00 | 890261.10 | 513594.70 | 298625.00 | 191140.90 | 233368.10 | 129672.00 | 112097.30 | 68377.90 |
| 归属于母公司股东利润 |
828731.90 | 935260.80 | 1069000.00 | 881084.50 | 509255.70 | 295361.30 | 185128.80 | 226052.30 | 122709.30 | 97497.99 | 34896.80 |
| 归属于非控制股股东利润 |
9643.10 | 11634.70 | 10771.80 | 8889.80 | 3879.20 | 2601.50 | 5685.80 | 7315.80 | 6962.70 | 14599.30 | 33481.10 |
| 归属于非股东利润 |
-- | -- | 14.90 | 286.80 | 459.80 | 662.20 | 326.30 | -- | -- | -- | -- |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 其他综合收益 |
-3788.60 | 18571.90 | 8692.10 | 29310.80 | -51088.80 | 8765.00 | 10882.40 | 121.90 | 1123.20 | 9361.80 | 496.50 |
| 综合收益总额 |
834586.40 | 965467.40 | 1088479.00 | 919571.80 | 462505.90 | 307390.00 | 202023.30 | 233490.00 | 130795.20 | 121459.10 | 68874.40 |
| 归属于母公司股东综合收益总额 |
825521.50 | 954119.10 | 1077846.00 | 910913.80 | 458879.00 | 304093.30 | 195450.40 | 226772.70 | 123659.20 | 106831.20 | 34689.20 |
| 归属于非控制股股东综合收益总额 |
9064.90 | 11348.30 | 10633.50 | 8658.10 | 3626.90 | 3296.70 | 6572.90 | 6717.30 | 7136.00 | 14627.90 | 34185.20 |